Prize4Life

Accelerating the discovery of treatments and a cure for ALS, Lou Gehrig's Disease, using powerful incentives to attract new people and drive innovation.

[Prize4Life @Prize4Life]

An important message from Prize4Life https://t.co/Wl3PuRSAif

[The ALS Association @alsassociation]

Read our synopsis of @sciam’s advances in #ALS research by @MayoClinic’s Dr. Petrucelli & @StanfordMed’s Dr. Gitler: https://t.co/MdsWqKcKBq

[Prize4Life @Prize4Life]

More on masitinib's 2nd phase 3... https://t.co/bIvZRvPCl8

[ALS Research Forum @ALSResForum]

#ICYMI A 2nd phase 3 #clinicaltrial of masitinib for #ALS #MND is planned. Sites: US, Canada & Europe. https://t.co/hBcoDtBlab @alsadvocacy

[Prize4Life @Prize4Life]

Our sister organization in Israel is organizing #Global Hug on June 21. Mark your calendar 🤗 https://t.co/BdCchceUp1

[Prize4Life @Prize4Life]

AB Science to conduct second Phase 3 study on #masitinib!! https://t.co/76k0RB6K8w

[ALS Research Forum @ALSResForum]

This just in - AB Science confirms that a 2nd phase 3 study of #masitinib in #ALS #MND is expected to begin Q3 2017 https://t.co/V3qH3KUWgE

[ALS Research Forum @ALSResForum]

Final week 2 apply 4 funding 4 your potential strategy 4 #ALS #MND from TREAT ALS. LOIs due: 5/23. https://t.co/sgDmvhQRnr @alsassociation

[Prize4Life @Prize4Life]

Nice coverage @ALSResForum! https://t.co/OBxoI9UmJb

[ALS Research Forum @ALSResForum]

Experts weigh in on #edaravone, now FDA-approved for the treatment of #ALS #MND in the US. #Radicava #Radicut https://t.co/nfh27cmxF9

[Prize4Life @Prize4Life]

Nice summary of ALS Drug Company Working Group meeting & Prize4Life award ceremony! Thank you to @alsassociation for being great co-hosts! https://t.co/RI7BopapIN

[The ALS Association @alsassociation]

Another successful #ALS Drug Company Working Group meeting – full of hope and collaboration! Learn more: https://t.co/ExvvBj8DQG

[Prize4Life @Prize4Life]

In case you missed @alsassociation webinar on Radicava, it was recorded! https://t.co/KMQLFUHoSA

[The ALS Association @alsassociation]

If you were unable to join our Radicava webinar please click here for the recording: https://t.co/HdVjZvn57S Thanks to all who participated!

[ALS Research Forum @ALSResForum]

A new potential therapy aims 2 target most cases of #ALS #MND by reducing TDP-43 aggregation https://t.co/YPu0wqixmy #ataxin-2 #ASOs @nature

[Prize4Life @Prize4Life]

Thrilled to formally award Dr. Barkats and Dr. Biferi (joined by their wonderful team!) the $1M Avi Kremer #ALS Treatment Prize!

[Prize4Life @Prize4Life]

We are so proud of our founder Avi Kremer! Featured on Israeli TV this past weekend. https://t.co/TYEIdpW1bf

[Prize4Life @Prize4Life]

A potential new target! https://t.co/fIlIirpwLR

[ALS Research Forum @ALSResForum]

Could microbial changes in the gut contribute to #ALS #MND? https://t.co/FZCvIztgaG #microbiome #neuroinflammation @MGHNeurology @neurobank

[ALS Research Forum @ALSResForum]

Check out our newsletter to find out about the latest news, jobs, meetings and funding opportunities in #ALS #MND https://t.co/pK0yLtkGBW

[Prize4Life @Prize4Life]

The inflammatory biomarker #CRP may help clinicians prognose #ALS https://t.co/cllHuaqeVT

[ALS Research Forum @ALSResForum]

The biomarker serum #CRP may help clinicians prognose #ALS by identifying fast progressors #NP001 #responderanalysis https://t.co/J5zfk3uyHj

[Prize4Life @Prize4Life]

DYK: 90% of #ALS cases are sporadic? Find out more https://t.co/oCeJ46jzm6

[The ALS Association @alsassociation]

DYK: 90% of #ALS cases are sporadic? Find out more about sporadic ALS from @UCSanDiego’s Dr. Sandrine Da Cruz: https://t.co/mksF6is8Q6

[Prize4Life @Prize4Life]

CDC - Amyotrophic Lateral Sclerosis: National #ALS Biorepository - @CDCgov https://t.co/N9oH9wafVU

[ALS Research Forum @ALSResForum]

Check out our newsletter to find out about the latest news, funding, meeting and job opportunities in #ALS #MND https://t.co/nYmLVbtpkR

[Prize4Life @Prize4Life]

Multiple growth factors may be needed to protect MNs & thus provide the most therapeutic benefit in #ALS https://t.co/oJgRGRDJmE

[ALS Research Forum @ALSResForum]

Multiple growth factors may be needed to protect MNs & thus provide the most therapeutic benefit in #ALS https://t.co/OuMORHcK3S #GDNF #HGF